Tumor biological immune cell therapy for pancreatic cancer

73-year-old Li Fenglan is currently fighting pancreatic cancer. She never thought that she would get such a terrible disease, but through her life, the cause of pancreatic cancer can be traced.

Li Fenglan is a person with a story, but the story has long been forgotten and no one knows it. We only know that the old lady used to smoke cigarettes. In that era, it was rare for women to smoke, but Li Fenglan smoked every day, and her face was full of sorrow. According to insiders, Li Fenglan's alcohol tolerance was also amazing. Someone saw her drink a bottle of white wine at home without changing her expression.

It is better to say less about these things, because Li Fenglan could not resist the wheel of time. Wrinkles had appeared on her face decades ago. She smoked less and less, and almost no one has seen her drinking for a long time. The only thing that remained unchanged was the sadness on her face.

What is more serious is that Li Fenglan has been suffering from abdominal pain recently. She could not bear it any longer and went to the hospital for treatment. The doctor performed B-ultrasound and CT examinations for her. After diagnosis, there was a 2.2*2.3 tumor in the pancreatic head with uneven density. The degree of enhancement in the arterial phase after enhancement was lower than that of the normal pancreas sagittal. There were multiple lower density foci inside. The portal vein and delayed phase were still low density, and the edge was surrounded by a ring-shaped enhancement band. The distal pancreatic duct was slightly dilated, the intrabiliary bile duct was slightly dilated, and the gallbladder was slightly enlarged. The blood vessels around the tumor were not affected. No enlarged lymph nodes were found in the retroperitoneal cavity. There was a cyst in the left kidney, and no mass was found in the liver, gallbladder, spleen, right kidney, and bilateral adrenal glands.

Because the elderly man was too old, surgical treatment was not recommended, so the hospital prescribed chemotherapy for him, but the effect was not good. Later, it was recommended to combine the treatment with CLS (tumor biological immune cell therapy) to eliminate side effects, improve resistance, and kill cancer cells fundamentally.

After Li Fenglan received a course of treatment, CT scans showed that the tumor had not spread and her condition was under control. Currently, Li Fenglan is still receiving further treatment.